Ezutromid Completed Phase 2 Trials for Duchenne's Muscular Dystrophy (DMD) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02858362PoC Study to Assess Activity and Safety of SMT C1100 (Ezutromid) in Boys With DMD